OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025
OSR Holdings (NASDAQ: OSRH) will host a Virtual Investor Event on August 6, 2025, at 8:00 a.m. ET to provide comprehensive corporate updates and strategic direction. The event will feature presentations from senior executives including CEO Peter Hwang, CSO Dr. Constance H枚fer, and Global IR Tim Smith.
Key agenda items include updates on subsidiary operations, R&D pipeline developments, capital allocation strategy, and the company's blockchain initiatives. Notable focus areas include Vaximm's T-cell immunotherapies, Darnatein's DRT101 DMOAD candidate, and the Woori IO acquisition for noninvasive CGM development.
The virtual event will be accessible via livestream, with registration opening on August 4 through the company's website. A replay will be available afterward on OSR Holdings' Investor Relations website.
OSR Holdings (NASDAQ: OSRH) organizzer脿 un Evento Virtuale per Investitori il 6 agosto 2025 alle 8:00 ET per fornire aggiornamenti aziendali completi e indicazioni strategiche. L'evento includer脿 presentazioni da parte dei dirigenti senior, tra cui il CEO Peter Hwang, il CSO Dr. Constance H枚fer e il responsabile delle Relazioni con gli Investitori Globali Tim Smith.
Gli argomenti principali riguarderanno aggiornamenti sulle operazioni delle controllate, lo sviluppo della pipeline di R&S, la strategia di allocazione del capitale e le iniziative blockchain dell'azienda. Particolare attenzione sar脿 dedicata alle immunoterapie T-cell di Vaximm, al candidato DMOAD DRT101 di Darnatein e all'acquisizione di Woori IO per lo sviluppo di CGM non invasivi.
L'evento virtuale sar脿 accessibile tramite livestream, con registrazione aperta dal 4 agosto sul sito web dell'azienda. Successivamente sar脿 disponibile una replica sul sito delle Relazioni con gli Investitori di OSR Holdings.
OSR Holdings (NASDAQ: OSRH) organizar谩 un Evento Virtual para Inversores el 6 de agosto de 2025 a las 8:00 a.m. ET para ofrecer actualizaciones corporativas completas y la direcci贸n estrat茅gica. El evento contar谩 con presentaciones de ejecutivos senior, incluyendo al CEO Peter Hwang, la CSO Dra. Constance H枚fer y el responsable global de relaciones con inversores Tim Smith.
Los temas clave incluyen actualizaciones sobre las operaciones de las subsidiarias, desarrollos en la cartera de I+D, estrategia de asignaci贸n de capital y las iniciativas blockchain de la compa帽铆a. Se destacar谩n las inmunoterapias de c茅lulas T de Vaximm, el candidato DMOAD DRT101 de Darnatein y la adquisici贸n de Woori IO para el desarrollo de CGM no invasivos.
El evento virtual ser谩 accesible v铆a transmisi贸n en vivo, con registro disponible a partir del 4 de agosto en el sitio web de la empresa. Posteriormente, habr谩 una repetici贸n disponible en la p谩gina de Relaciones con Inversores de OSR Holdings.
OSR Holdings (NASDAQ: OSRH)电� 2025雲� 8鞗� 6鞚� 鞓れ爠 8鞁� ET鞐� 臧�靸� 韴瀽鞛� 鞚措菠韸鸽ゼ 臧滌禍頃橃棳 韽磩鞝侅澑 旮办梾 鞐呺嵃鞚错姼鞕� 鞝勲灥鞝� 氚╉枼鞚� 鞝滉车頃� 鞓堨爼鞛呺媹雼�. 鞚措矆 頄夓偓鞐惖鐢 CEO 頂柬劙 頇�, CSO 旖橃姢韮勳姢 須岉嵓 氚曥偓, 旮�搿滊矊 IR 韺� 鞀る鞀� 霌� 瓿犾渼 瓴届榿歆勳潣 氚滍憸臧� 韽暔霅╇媹雼�.
欤检殧 鞎堦贝鞙茧电� 鞛愴殞靷� 鞖挫榿 順勴櫓, 鞐瓣惮臧滊皽 韺岇澊頂勲澕鞚� 臧滊皽, 鞛愲掣 氚半秳 鞝勲灥, 須岇偓鞚� 敫旊觳挫澑 鞚措媹靺旐嫲敫� 鞐呺嵃鞚错姼臧� 韽暔霅╇媹雼�. 韸鬼瀳 Vaximm鞚� T靹疙彫 氅挫棴旃橂鞝�, Darnatein鞚� DRT101 DMOAD 頉勲炒氍检, 牍勳龚鞀奠爜 CGM 臧滊皽鞚� 鞙勴暅 Woori IO 鞚胳垬臧� 欷戩爯鞝侅溂搿� 雼る歆戨媹雼�.
臧�靸� 鞚措菠韸傅鐢 霛检澊敫� 鞀ろ姼毽检溂搿� 鞝滉车霅橂┌, 霌彪鞚� 8鞗� 4鞚�攵�韯� 須岇偓 鞗轨偓鞚错姼毳� 韱淀暣 臧�電ロ暕雼堧嫟. 鞚措菠韸� 膦呺 頉� OSR Holdings 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼鞐愳劀 雼れ嫓氤搓赴搿� 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟.
OSR Holdings (NASDAQ : OSRH) organisera un 茅v茅nement virtuel pour les investisseurs le 6 ao没t 2025 脿 8h00 ET afin de fournir des mises 脿 jour compl猫tes sur l'entreprise et sa strat茅gie. L'茅v茅nement comprendra des pr茅sentations des cadres sup茅rieurs, dont le PDG Peter Hwang, la directrice scientifique Dr. Constance H枚fer, et le responsable des relations investisseurs globales Tim Smith.
Les points cl茅s 脿 l'ordre du jour incluent des mises 脿 jour sur les op茅rations des filiales, les d茅veloppements du pipeline R&D, la strat茅gie d'allocation du capital et les initiatives blockchain de la soci茅t茅. Les domaines d'int茅r锚t particuliers sont les immunoth茅rapies T-cell de Vaximm, le candidat DMOAD DRT101 de Darnatein, ainsi que l'acquisition de Woori IO pour le d茅veloppement de CGM non invasifs.
L'茅v茅nement virtuel sera accessible en direct, avec une inscription ouverte 脿 partir du 4 ao没t via le site web de la soci茅t茅. Une rediffusion sera disponible ensuite sur le site des relations investisseurs d'OSR Holdings.
OSR Holdings (NASDAQ: OSRH) veranstaltet am 6. August 2025 um 8:00 Uhr ET ein virtuelles Investorenevent, um umfassende Unternehmensupdates und strategische Ausblicke zu geben. Das Event beinhaltet Pr盲sentationen von F眉hrungskr盲ften, darunter CEO Peter Hwang, CSO Dr. Constance H枚fer und Global IR Tim Smith.
Wichtige Programmpunkte sind Updates zu den Tochtergesellschaften, Entwicklungen in der F&E-Pipeline, Kapitalallokationsstrategie und Blockchain-Initiativen des Unternehmens. Besondere Schwerpunkte liegen auf den T-Zell-Immuntherapien von Vaximm, dem DMOAD-Kandidaten DRT101 von Darnatein sowie der 脺bernahme von Woori IO zur Entwicklung nicht-invasiver CGM.
Das virtuelle Event ist per Livestream zug盲nglich, die Registrierung 枚ffnet am 4. August 眉ber die Website des Unternehmens. Eine Aufzeichnung wird anschlie脽end auf der Investor-Relations-Website von OSR Holdings verf眉gbar sein.
- None.
- None.
The event will provide shareholders and prospective investors with a detailed update of the Company's strategic direction, subsidiary performance, capital allocation, and pipeline R&D. Senior members of the OSRH executive team will be presenting.
Event Details
Date: Wednesday, August 6, 2025
Time: 8:00 a.m. ET / 2:00 p.m. CEST / 9:00 p.m. KST
Location: Virtual (livestream access)
Registration: Opens Monday, August 4 at
Replay: Available after the event on the OSR Holdings Investor Relations website.
Agenda Highlights
- Corporate overview and strategic vision
- Subsidiary and R&D pipeline updates:
- Vaximm: Tailored, Antigen-specific in vivo T-cell Immunotherapies
- Darnatein: DRT101 鈥� a potent DMOAD candidate
- Woori IO acquisition: The opportunity for noninvasive CGM
- Equity Line of Credit (ELOC) financing strategy
- Blockchain & Tokenization strategy
- Live Q&A with management
"This event is a timely opportunity to engage with our shareholders and the broader investment community as we move into a transformative stage in OSR's growth," said Peter Hwang, CEO of OSRH. "We look forward to showcasing the strength of our platform, the progress we've made, and the catalysts ahead. We are committed to transparency, disciplined execution, and delivering meaningful value to all stakeholders in the coming months."
Featured Speakers:
- Mr. Peter Hwang 鈥� Chief Executive Officer
- Dr. Constance H枚fer 鈥� Chief Scientific Officer
- Mr. Tim Smith 鈥� Global Investor Relations
About OSR Holdings, Inc.
OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare holding company dedicated to advancing biomedical innovation approaches to health and wellness to support global health outcomes. Through its subsidiaries, OSRH is engaged in immuno鈥憃ncology, regenerative biologics, and medical device distribution. OSRH's vision is to acquire and operate a portfolio of innovative healthcare and wellness companies, improving patient care through cutting鈥慹dge research and development. For more information, visit www.OSR鈥慔oldings.com.聽
View original content to download multimedia:
SOURCE OSR Holdings
FAQ
When is OSR Holdings (NASDAQ: OSRH) hosting its Virtual Investor Event in 2025?
What topics will be covered at OSR Holdings' Virtual Investor Event?
How can investors access OSR Holdings' Virtual Investor Event?
Who are the key speakers at OSR Holdings' upcoming investor event?
